June 26, 2019
Antibe Therapeutics’s CEO letter to shareholders
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF): To our shareholders, As we approach the end of Phase 2 development…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Antibe